All In Biotech

Free tool

FAERS Monitor: Dhivy

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214869 or its brand name (Dhivy, Carbidopa, Levodopa). Reports on generic versions are filed under their own applications.

Reports

3,539

Serious

2,105

59% of reports

Hospitalization

1,034

Death reported

566

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hallucination479
  • fall436
  • death370
  • drug ineffective354
  • confusional state217
  • product dose omission issue211
  • dizziness202
  • fatigue199
  • parkinson^s disease195
  • gait disturbance175
  • nausea172
  • tremor170
  • asthenia167
  • condition aggravated160
  • urinary tract infection159

Reports by year received

View as table
YearReports
20044
20054
20111
201214
201333
201449
201582
2016103
2017170
2018284
2019315
2020430
2021290
2022116
2023470
2024638
2025530
20266

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,620 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
hallucinationSignal47938.035.017,176
confusional stateSignal2178.07.01,329
fallSignal4367.87.12,614
tremorSignal1706.15.3724
urinary tract infectionSignal1595.54.8592
gait disturbanceSignal1755.44.7635
product dose omission issueSignal2114.33.7532
condition aggravatedSignal1603.12.7233
astheniaSignal1672.62.3172
deathSignal3702.62.3363
dizzinessSignal2022.42.1169
drug ineffective3541.61.484
fatigue1991.51.336
nausea1721.31.111
parkinson^s disease1950.00.01,153,965

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.